Takeda Pharmaceutical (TAK) EPS (Basic) (2017 - 2026)
Takeda Pharmaceutical (TAK) posted EPS (Basic) of $4.96 for Q2 2026, down 10.33% on a QoQ basis from $5.53 in Q1 2026, and down 17.09% year-over-year from $5.98 in Q2 2025.
Analysis
Takeda Pharmaceutical (TAK) EPS (Basic) (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical has reported EPS (Basic) for 10 years, with the latest figure at $4.96 in Q2 2026.
- On a quarterly basis, EPS (Basic) fell 17.09% year-over-year to $4.96 in Q2 2026; TTM through Jun 2026 was $4.01, a 76.1% decrease from a year earlier, with the FY2026 full-year figure at -$6.79, down 237.48% from the prior year.
- EPS (Basic) was $4.96 for Q2 2026 at Takeda Pharmaceutical, down from $5.53 in the prior quarter.
- The five-year high for EPS (Basic) was $14.03 in Q3 2023, with the low at -$16.68 in Q4 2025.
- Average EPS (Basic) over 5 years is $3.86, with a median of $5.25 recorded in 2026.
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) soared 918.32% in 2023, then tumbled 420.03% in 2024.
- Over 5 years, EPS (Basic) stood at $5.93 in 2022, then tumbled by 74.86% to $1.49 in 2023, then sank by 420.03% to -$4.77 in 2024, then plunged by 249.52% to -$16.68 in 2025, then surged by 129.73% to $4.96 in 2026.
- The last three EPS (Basic) figures came in at $4.96 (Q2 2026), $5.53 (Q1 2026), and -$16.68 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.46 Bn | 622.70 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 440.39 Bn | 433.82 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | 1.68 |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 44.36 Bn | 44.36 Bn | - | -3.06 |
| 8 | Incyte | 25.34 Bn | 20.81 Bn | 1.57 Bn | 2.92 |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 7.82 |
| 10 | Takeda Pharmaceutical | 2.61 Bn | -3.19 Bn | 5.10 Bn | 4.96 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.96 |
| Mar 31, 2026 | 5.53 |
| Dec 31, 2025 | -16.68 |
| Sep 30, 2025 | 10.22 |
| Jun 30, 2025 | 5.98 |
| Mar 31, 2025 | 5.67 |
| Dec 31, 2024 | -4.77 |
| Sep 30, 2024 | 9.95 |
| Jun 30, 2024 | 4.30 |
| Mar 31, 2024 | 4.52 |
| Dec 31, 2023 | 1.49 |
| Sep 30, 2023 | 14.03 |
| Jun 30, 2023 | 4.62 |
| Mar 31, 2023 | 5.63 |
| Dec 31, 2022 | 5.93 |
| Sep 30, 2022 | 3.15 |
| Jun 30, 2022 | 5.71 |
| Mar 31, 2022 | -0.69 |
| Dec 31, 2021 | 8.11 |
| Sep 30, 2021 | 2.94 |